CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043321804
- Phone
- (608) 441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- D Other Notice of Sales of Unregistered Securities
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Change in control · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
- NT 10-K Other NT 10-K
- 8-K Event Executive or director change
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Unregistered share sale
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- 424B3 Offering Prospectus
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 424B3 Offering Prospectus
Page 52 of 61 · 1,218 filings